-
Physical symptoms are quite common among patients with depression. These symptoms tend to improve during the first month of therapy with serotonin-antagonists. Most symptoms will plateau in months to follow.
-
Esophageal adenocarcinoma (EAC), GERD, and Barretts esophagus (BE) are all on the rise, and there is no doubt that BE is a major risk factor for EAC. However, many unanswered questions surround screening GERD patients for BE and cancer.
-
The FDA has approved a low dose estradiol transdermal patch for prevention of osteoporosis in menopausal women.
-
Folate Therapy and In-Stent Restenosis and Coronary Stenting; Quinapril Reduces Markers of Oxidative Stress in the Metabolic Syndrome; Donepezil in Patients with Alzheimers
-
"EMTALA: The Essential Guide to Compliance" from Thomson American Health Consultants, publisher of Emergency Medicine Reports, explains how the changes to EMTALA will affect emergency departments and off-campus clinics.
-
-
Greenfield RH. Behind the banning of ephedra: Misuse, abuse, and dangers. Altern Med Alert 2004;7(3):25-33.
-
Some 20 trials dedicated to the pursuit of more rapid and more complete reperfusion have been published in the last few years, and sorting through the literature can be dizzying. The following article will highlight the major recent developments in AMI reperfusion therapy. It will accent which of the many therapeutic options currently are considered acceptable, and present treatment guidelines for the emergency physician faced with the patient who presents to the emergency department with acute ST elevation MI.
-
-
Kim YH. Mindulness meditation and chronic pain. Altern Med Alert 2004;7(3):33-35.